Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Revium Rx (RVRC) EBIT (2026)

Updated

Revium Rx's EBIT was -$732,000 in Q2 2026.

Analysis

Revium Rx (RVRC) EBIT (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - -732,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -732,000.00
API Access

Revium Rx EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=RVRC&period=max&api_key=YOUR_API_KEY